IL-1 Receptor Antagonist Antibodies in Idiopathic Recurrent Pericarditis
This cohort study investigates the prevalence and role of autoantibodies targeting the endogenous interleukin 1 (IL-1) receptor antagonist in patients with recurrent pericarditis with an inflammatory phenotype.
Authors
- Antonio Luca Brucato (ORCID: https://orcid.org/0000-0002-7566-5600)
- Evi Regitz
- Lorenz Thurner
- Enrica Negro (ORCID: https://orcid.org/0000-0002-6673-5101)
- Jochen Pfeifer (ORCID: https://orcid.org/0000-0003-1673-6285)
- Karin Klingel (ORCID: https://orcid.org/0000-0003-0203-2498)
- Massimo Imazio (ORCID: https://orcid.org/0000-0002-5722-0245)
- Alida L.P. Caforio (ORCID: https://orcid.org/0000-0002-4901-5655)
- Maddalena Alessandra Wu (ORCID: https://orcid.org/0000-0003-1078-1632)
- Elisa Ceriani (ORCID: https://orcid.org/0000-0003-2711-7148)
- Christoph Kessel (ORCID: https://orcid.org/0000-0002-0638-2949)
- Silvia Berra (ORCID: https://orcid.org/0000-0003-1151-7040)
- Natalie Fadle
- Sabrina Fuehner (ORCID: https://orcid.org/0009-0004-1237-1447)
- Bernhard Thurner
Institutions
- University of Udine (IT)
- University of Padua (IT)
- Kempten University of Applied Sciences (DE)
- University Hospital Münster (DE)
- Ospedale Santa Maria della Misericordia di Udine (IT)
- ASST Fatebenefratelli Sacco (IT)
- Saarland University (DE)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2025-10-09
- DOI
- https://doi.org/10.1001/jamanetworkopen.2025.36691
- Primary Topic
- Pericarditis and Cardiac Tamponade
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Kiniksa Pharmaceuticals
- Swedish Orphan Biovitrum